ART4 and COVID-19: In this study, we identified two immunodominant linear B-cell epitopes, S14P5 and S21P2, on the SARS-CoV-2 S glycoprotein, and further assessed the functional capacity of COVID-19 patient sera antibodies against these regions using a pseudotyped lentivirus assay.